Free radical pathology and antioxidant defense in schizophrenia: A review

Schizophrenia Research

Volumn 19, Issue 1, 1996, Pages 1-17

  Mahadik, Sahebarao P ^a   Mukherjee, Sukdeb ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

Antioxidants; CNS injury; Free radicals; Schizophrenia

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CATALASE; ENZYME; FREE RADICAL; GLUTATHIONE PEROXIDASE; HALOPERIDOL; HYDROXYL RADICAL; NITRIC OXIDE; POLYUNSATURATED FATTY ACID; SUPEROXIDE; SUPEROXIDE DISMUTASE;

CELL DAMAGE; CENTRAL NERVOUS SYSTEM; ETIOLOGY; HUMAN; LIPID PEROXIDATION; MEMBRANE DAMAGE; NERVOUS SYSTEM INJURY; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA;

EID: 0029923725     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/0920-9964(95)00049-6     Document Type: Article

References (176)

1. Abdalla, D.S.P., Manteiro, H.P., Olivera, J.A.C. and Bechara, C.H. (1986) Activities of superoxide dismutase and glutathione peroxidase in schizophrenic and manic depressive patients. Clin. Chem. 32, 805-807.
2. Adler, L.A., Peselo, E., Rotrosen, J., Duncan, E., Lee, M., Rosenthal, M. and Angrist, B. (1993) Vitamin E treatment of tardive dyskinesia. Am. J. Psychiatry 150, 1405-1407.
3. Akbarian, S., Bunney, W.E., Potkin, S.G., Wigal, S.B., Hagman, J.O., Sandman, C.A. and Jones, E.G. (1993a) Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch. Gen. Psychiatry 50, 169-177.
4. Akbarian, S., Vinuela, A., Kim, J.J., Potkin, S.G., Bunney, W.E. and Jones, E.G. (1993b) Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development. Arch. Gen. Psychiatry 50, 178-187.
5. Allen, R.G. (1991) Oxygen-reactive species and antioxidant responses during development: the metabolic paradox of cellular differentiation. Proc. Soc. Exptl. Biol. Med. 196, 117-129.
6. Allen, R.G. and Balin, A.K. (1988) Developmental changes in the superoxide dismutase activity of human skin fibroblasts are maintained in vitro and are not caused by oxygen. J. Clin. Invest. 82, 731-734.
7. Allen, R.G. and Balin, A.K. (1989) Oxidative influence on development and differentiation: an overview of a free radical theory of development. Free Radical Biol. Med. 6, 631-661.
8. Allen, R.G. and Venkatraj, V.S. (1992) Oxidants and antioxidants in development and differentiation. J. Nutr. 122, 631-635.
9. Allebeck, P. (1989) Schizophrenia: a life-threatening disease. Schizophr. Bull. 15, 81-89.
10. Ames, B.N., Cathcart, R., Schwier, E. and Hochstein, P. (1981) Uric acid, an antioxidant in humans against oxidant-and radical-caused aging and cancer. A hypothesis. Proc. Natl. Acad. Sci. USA 78, 6858-6862.
11. Ames, B.A., Shingenaga, M.K. and Park, E.-M. (1991) Oxyradicals and DNA damage. In: Davies, K.J.A. (Ed.). Oxidation Damage and Repair: Chemical Biological and Medical Aspects. Pergamon Press, Elmsford, NY. pp. 181-187.
12. Aruoma, O.I. and Halliwell, B. (1987) Superoxide-dependent and ascorbate-dependent formation of hydroxyl radicals from hydrogen peroxide in the presence of iron. Biochem. J. 241, 273-278.
13. Axelrod, J. (1990) Receptor-mediated activation of phospholipase A2 and arachidonic acid release in signal transduction. Biochem. Soc. Trans. 18, 503-507.
14. Banes, F.M. and Bird, E.D. (1987) An analysis of the arrangement of neurons in the cingulate cortex of schizophrenic patients. Arch. Gen. Psych. 44, 608-616.
15. Beauclair, L., Vinogradov, S., Riney, S.J., Csernansky, J.G. and Hollister, L.E. (1987) An adjunctive role for ascorbic acid in the treatment of schizophrenia? J. Clin. Psychopharm. 7, 282-283.
16. Beckman, J.S. (1991) The double-edged role of nitric oxide in brain function and superoxide-mediated injury. J. Dev. Physiol. 15, 53-59.
17. Bernsohn, J. and Cohen, S.R. (1972) Polyenoic fatty acid metabolism of phosphoglycerides in developing brain. In: Ciba Foundation Symposium, Elsevier, New York. pp. 159-178.
18. - with unsaturated fatty acids. J. Biol. Chem. 258, 4759-4761.
19. Bloom, F. (1993) Comment: Advancing a neurodevelopmental origin for schizophrenia. Arch. Gen. Psychiatry 50, 224-227.
20. Bogerts, B., Meertz, E. and Schonfeldt-Bausch, R. (1985) Basal ganglia and limbic system pathology in schizophrenia: a morphometric study of brain volume and shrinkage. Arch. Gen. Psychiatry 42, 784-91.
21. Bogerts, B., Ashtari, M., Degreef, G., Alvi, J.M.J., Bilder, R. M. and Lieberman, J.A. (1990) Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia. Psychiat. Res. Neuroimaging 35, 1-13.
22. Borg, D.C. and Schaich, K.M. (1988) Iron and iron-derived radicals. In: Halliwell, B. (Ed.). Free Radicals and Tissue Injury. Proc. Upjohn Sympo. FASEB Press, Rockville, Bethesda, MD. pp. 20-26.
23. Braff, D.L. (1993) Information processing and attention dysfunctions in schizophrenia. Schizophr. Bull. 19, 233-260.
24. Brannan, T.S., Maker, H.S., Weiss, C. and Cohen, G. (1980) Regional distribtuion of glutathione peroxidase in the adult rat brain. J. Neurochem. 35, 1013-1014.
25. Brown, J.S. Jr. (1994) Role of selenium and other trace elements in the geography of schizophrenia. Schizophr. Bull. 20, 387-398.
26. Buckman, T.D., Kling, A.S., Eiduson, S., Sutphin, M.S. and Steinberg, A. (1987) Glutathione peroxidase and CT scan abnormalities in schizophrenia. Biol. Psychiatry 22, 1349-1356.
27. Buckman, T.D., Kling, A.S., Eiduson, S., Sutphin, M.S., Steinberg, A. and Eiduson, S. (1990) Platelet glutathione peroxidase and monoamine oxidase activity in schizophrenics with CT scan abnormalities: relation to psychosocial variables. Psychiatry Res. 31, 1-14.
28. Burton, G.W. and Ingold, K.U. (1989) Vitamin E as an in vitro and in vivo antioxidant. Ann. N.Y. Acad. Sci. 570, 7-22.
29. Burton, G.W. and Ingold, K.U. (1990) Mechanisms of antioxidant action: preventive and chain-breaking antioxidants. In: Miguel, A., Quintanilha, A.T. and Weber, H. (Eds.). CRC Handbook of Free Radicals and Antioxidants in Biomedicine. Vol. II. CRC Press Inc. Boca Raton, FL. pp. 29-43.
30. Cadet, J.L. and Lohr, J.B. (1987) Free radicals and the developmental pathobiology of schizophrenic burnout. Integr. Psychiatry 5, 40-48.
31. Cadet, J.L. and Lohr, J.B. (1989) Possible involvement of free radicals in neuroleptic-induced movement disorders. Ann. N. Y. Acad. Sci. 570, 176-185.
32. Cadet, J.L. and Perumal, A.S. (1990) Chronic treatment with prolixin causes oxidative stress in rat brain. Biol. Psychiatry 28, 738-740.
33. Carlsson, M. and Carlsson, A. (1990) Interactions between glutamate and monoaminergic system within basal ganglia - implications for schizophrenia and Parkinson's disease. Trends Neurol. Sci. 13, 272-276.
34. Cathcart, R., Schwiers, E. and Ames, B.N. (1984) Detection of picomole levels of lipid hydroperoxides using a dichlorofluorescein fluorescent assay. Meth. Enzymology. 105, 352-358.
35. Chan, P.H., Longar, S. and Fishman, R.A. (1987) Protective effects of liposome-trapped superoxide dismutase on post-traumatic brain edema. Ann. Neurol. 21, 282-286.
36. Chan, P.H., Chu, L., Chen, S.F., Carlson, E.J. and Epstein, C.J. (1990) Reduced neurotoxicity in transgenic mice overexpressing human copper-zinc-superoxide dismutase. Stroke 21 (Suppl. III), pp. 80-82.
37. Chang, J., Musser, J.H. and McGregor, H. (1987) Phospholipase A2: function and pharmacological regulation. Biochem. Pharmacol. 36, 2429-2436.
38. Cohen, G. (1984) Oxy-radical toxicity in catecholamine neurons. Neurotoxicology 5, 77-82.
39. Cohen, G. and Greenwald, R.A. (Eds.) (1983) Oxyradicals and Their Scavenger Systems. Vol. 1. Molecular Aspects. Proc. Third Intl. Conf. om Superoxide and Superoxide Dismutase. Elsevier Publishing Co. Inc., Ellenville, New York.
40. Cohen, G. and Hochstein, P. (1963) Glutathione peroxidase: The primary agent for the elimination of hydrogen peroxide in erythrocytes. Biochemistry 2, 1420-1428.
41. Cohen, G. and Spina, M.B. (1989) Deprenyl supresses the oxidant stress associated with increased dopamine turnover. Ann. Neurol. 26, 689-690.
42. Cohen, M.R., Sailer, V., McAmis, B. and Jenkins, P. (1986) Superoxide dismutase activity in fibroblasts from patients with schizophrenia. Biol. Psychiatry 21, 322-324.
43. Cohen, M.R., Gutman, R. and McAmis, W. (1987) Cultured skin fibroblasts: Acute growth and susceptibility to damage. Psychiatry Res. 21, 43-47.
44. Costa, E., Cheney, D.L., Mao, C.C. and Maroni, F. (1978) Action of antischizophrenic drugs on the metabolism of monoamine, gamma-aminobutyric acid and acetylcholine in globus palidus, striatum, and n. accumbens. Fed. Proc. 37, 2408-2414.
45. Datta, N.S., Golder, N.W. and Hajra, A.K. (1981) Deficiency of enzymes catalyzing the biosynthesis of glycerol-ether lipids in Zellweger syndrome. N. Engl. J. Med. 311, 1080-1083.
46. Dawson, V.L., Dawson, T.M., London, E.D., Bredt, D.S. and Snyder, S.M. (19191) Nitric oxide mediated glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. USA 88, 6368-6371.
47. Dennis, E.A., Rhee, S.G., Billah, M.M. and Hannum, Y.A. (1991) Role of phospholipase in generating lipid second messenger signal transduction. FASEB J. 5, 2068-2077.
48. Dionisi, O., Galeotti, T., Terranva, T. and Azzi, A. (1975) Superoxide radicals and hydrogen peroxide formation in mitochondria from normal and neoplastic tissues. Biochim. Biophys. Acta. 403, 292-300.
49. Egan, M.T., Hyde, T.M., Albers, G.W., Elkashef, A., Alexander, R.C., Reeve, A., Blum, A., Saez, R.E. and Wyatt, R.J. (1992) Treatment of tardive dyskinesia with vitamin E. Am. J. Psychiat. 149, 773-777.
50. Elkashef, A.M., Ruskin, P.E., Bacher, N. and Barett, D. (1990) Vitamin in the treatment of tardive dyskinesia. Am. J. Psychiatry 147, 505-506.
51. Erkell, L.J. (1980) Differentiation of mouse neuroblastoma cells under increased oxygen tension. Expl. Cell. Biol. 48, 374-380.
52. Essali, M.A., Das, I., de Belletoche, J. and Hirsch, S.R. (1990) The platelet polyphopshoinositide system in schizophrenia: The effects of neuroleptic treatment. Biol. Psychiatry 28, 475-487.
53. Farooqui, A.A., Hirashima, Y. and Horrocks, L.A. (1992) Brain phospholipases and their role in signal transduction. In Bazan N.G. et al. (eds), Neurobiology of Essential Fatty Acids. New York: Plenum Press, pp. 11-25.
54. Fish, B., Marcus, J., Hans, S., Auerbach, J.G. and Perdue, S. (1992) Infants at risk for schizophrenia: Sequelae of a genetic neurointegrative defect. Arch. Gen. Psychiatry 49, 221-235.
55. Fisher, A.B. (1988) Intracellular production of oxygen-derived free radicals. In: Halliwell, B. (Ed). Free radicals and Tissue Injury. Proc. Upjohn Sympo. FASEB Press, Rockville, Bethesda, MD. pp. 34-42.
56. Frei, B., England, L. and Ames, B.N. (1989) Ascorbate is an outstanding antioxidant in human blood plasma. Proc. Natl. Acad. Sci. USA 86, 6377-6381.
57. Freedman, R., Stromberg, I., Seiger, A., Olson, L., Nordstrom, A.L., Wiesel, F.A., Bygdeman, M., Wetmore, C., Palmer, M. and Hoffer, B.J. (1992) Initial studies of embryonic transplants of human hippocampus and cerebral cortex derived from schizophrenic women. Biol. Psychiatry 32, 1148-1163.
58. Freeman, M.L., Scidmore, N.C., Malcolm, A.W. and Meredith, M.J. (1987) Diamide exposure, thermal resistance, and synthesis of stress (heat shock) proteins. Biochem. Pharmacol. 36, 21-29.
59. Fridovich, I. (1975) Superoxide dismutase. Annu. Rev. Biochem. 44, 147-159.
60. Fridovich, I. (1983) Superoxide radical: an endogenous toxicant. Annu. Rev. Pharmacol. 23, 239-257.
61. Fridovich, I. (1986) Biological effects of the superoxide radical. Arch. Biochem. Biophys. 247, 1-11.
62. Fried, R. and Mandel, P. (1975) Superoxide dismutase of mammalian nervous system. J. Neurochem. 24, 433-438.
63. Fried, R. Fried, L.W. and Babin D.R. (1970) The inhibition of reduction of tetrazolium by a protein from liver. Eur. J. Biochem. 16, 399-406.
64. Garthwate, J. (1991) Glutamate, nitric oxide and cell-cell signalling in the nervous system. TINS 14, 60-67.
65. Giller, E. (1980) The use of fibroblast cultures in in neuropsychiatric disorders. In Hanin, I. and Koslow, S.H. (eds), Physico-chemical methodologies in psychiatric research. New York: Raven Press, pp. 245-256.
66. Glazov, V.A. and Mamzev, V.P. (1976) Catalase in the blood and leucocytes in patients with nuclear schizophrenia. Zh. Nevropatol. Psikhiatr. 4, 549-552.
67. Glen, A.I.M., Glen, E.M.T., Horrobin, D.F., Vaddadi, K.S., Spellman, M., Morse-Fisher, N., Ellis, K., and Skinner, F.K. (1994) A red cell membrane abnormality in a subgroup of schizophrenic patients: Evidence for two diseases. Schizophr. Res. 12, 53-61.
68. Golse, B., Debray, Q., Puget, K. and Michelson, A.M. (1978) Dosages erythrocytaires de la superoxyde dismutases 1 et de 1a glutathion peroxydase dans les schizophrenies de liadulte. Nouv. Pr. Med. 7, 2070-2071.
69. Graham, D.G. (1978) Oxydative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol. Pharmacol. 14, 633-634.
70. Graham, D.G., Tiffany, S.M., Bell, W.R. and Gutknecht, W.F. (1978) Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-OH-dopamine, and related compounds towards C300 neuroblastoma cells in vitro. Mol. Pharmacol. 14, 644-653.
71. Groner, Y., Elroy-Stein, O., Avraham, K.B., Yaron, Y., Shikler, M., Knobler, H. and Rotman, G. (1990) Down syndrome clinical symptoms are manifested in transfected cells ansd transgenic mice overexpressing the human Cu/Zn-superoxide dismutase gene. J. Physiol. 84, 53-77.
72. Gutteridge, J.M.C. (1982) The role of superoxide and hydroxyl radicals in phospholipid peroxidation catalysed by iron salts. FEBS Lett. 150, 454-458.
73. Gutteridge, J.M.C. (1988) Lipid peroxidation: some problems and concepts. In: Halliwell, B. (Ed). Oxygen Radicals and Tissue Injury. Proc. Upjohn Symposium. FASEB Press, Rockville, Bethesda, MD. pp. 9-19.
74. Halliwell, B. (1978) Biochemical mechanisms accounting for the toxic action of oxygen on living organisms: the key role of superoxide dismutase. Cell. Biol. Intl. Rep. 2, 113-128.
75. Halliwell, B. (Ed.) (1988) Oxygen Radicals and Tissue Injury. Proceedings of an Upjohn Symposium. FASEB Press, Rockville, Bethesda, MD.
76. Halliwell, B. (1992) Reactive oxygen species and the central nervous system. J. Neurochem. 59, 1609-1623.
77. Halliwell, B. and Gutteridge, J.M.C. (1984) Oxygen toxicty, oxygen radicals, transition metals, and disease. Biochem. J. 219, 1-14.
78. Halliwell, B. and Gutteridge, J.M.C. (Eds.) (1985a) Free Radicals in Biology and Medicine. Clarendon Press, London.
79. Halliwell, B. and Gutteridge, J.M.C. (1985b) Oxygen radicals and the nervous system. Trends Neurol. Sci. 8, 22-26.
80. Halliwell, B. and Gutteridge, J.M.C. (1986) Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. Arch. Biochem. Biophys. 246, 501-515.
81. Halliwell, B. and Gutteridge, J.M.C. (1989) Free Radicals in Biology and Medicine. 2nd edit. Clarendon Press, Oxford.
82. Halliwell, B. and Gutteridge, J.M.C. (1990) Antioxidants of human extracellular fluids. Arch. Biochem. Biophys. 280, 1-8.
83. Harman, D. (1956) Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 11: 298-300.
84. Haugaard, N. (1968) Cellular mechanisms of oxygen toxicity. Physiol. Rev. 48, 311-345.
85. Hope, B.T., Michael, G.J., Knigge, K.M. and Vincent, S.R. (1991) Neuronal NADPH diaphorase is a nitric oxide syntahse. Proc. Natl. Acad. Sci. USA 88, 2811-2814.
86. Horrobin, D.F., Manku, M.S., Hillman, S., & Glen, I.A.M. (1991). Fatty acid levels in brains of schizophrenics and normal controls. Biol. Psychiatry, 30, 795-805.
87. Hudson, C.J., Young, L.T., Li, P.P. and Warsh, J.J. (1993) CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia. Synapse 13, 278-293.
88. Jackson, G.R., Apfell, L., Werrbacch-Perez, K. and Perez-Polo, J.R. (1990) Role of nerve growth factor in oxidant-antioxidant balance and neuronal injury. I. Stimulation of hydrogen peroxide resistance. J. Neurisci. Res. 25, 360-369.
89. Jakob, H. and Beckmann, H. (1986) Prenatal developmental disturbances in the limbic allocortex in schizophrenia. J. Neural. Transm. 65, 303-26.
90. Janero, D.R. (1990) Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radical Biol. & Medicine 9, 515-540.
91. Kaiya, H., Nishida, A., Imani, A., Nakashima, S., & Nozawa, Y. (1989). Accumulation of diacylglycerol in platelet phos-phoinositide turnover in schizophrenia: A biological marker of good prognosis? Biological Psychiatry, 26, 669-676.
92. Keshavan, M.S., Mallinger, A.G., Pettegrew, J.W. and Dippold, C. (1993) Erythrocyte membrane phospholipids in psychotic patients. Psych. Res. 49, 89-95.
93. Kramer, K., Voss, H.-P., Grimberger, J.A., Timmerman, H. and Bast, A. (1987) The effects of ischemia and recirculation, hypoxia and recovery on antioxidant factors and α-adrenoreceptor density: Is the damage in the erythrocytes a reflection of brain damage caused by complete cerebral ischemia and by hypoxia? Biochem. Biophys. Res. Commun. 149, 568-575.
94. Ku, H.-H., Brunk, U.T. and Sohal, R.S. (1993) Relationship between mitochondrial superoxide and hydrogen peroxide production and longevity of mammalisn species. Free Rad. Biol. Med. 15, 621-627.
95. Levine, R.L., Garland, D., Oliver, C.N., Amici, A., Climent, I., Lenz, A.-G., Ahn, B.-W., Shaltiel, S. and Stadtman, E.R. (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 186, 464-478.
96. Lewis, D.H. and Del Maestro, R. (1980) Free Radicals in Medicine and Biology. Proc. from the Pharmacia Symposium. Acta Physiol. Scand. Suppl. 492.
97. Lipton, S.A., Choi, Y.-B., Pan, Z.-S., Lei, S.Z., Chen, H.-S.V., Sucher, N.J., Loscalzo, J., Singel, D.J. and Stamler, J.S. (1993) A redox based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364, 626-632.
98. Lohr, J.B., Cadet, J.L., Lohr, M.A., Jeste, D.V. and Wyatt, R.J. (1987) Alpha-tocopherol in tardive dyskinesia. Lancet 1, 913-914.
99. Lohr, J.B., Cadet, J.L., Lohr, M.A., Larson, L., Wasli, E., Wade, L., Hylton, R., Vidoni, C., Jeste, D.V. and Wyatt, R.J. (1988) Vitamin E in the treatment of tardive dyskinesia: the possible involvement of free radical mechanism. Schizophr. Bull. 14, 291-296.
100. Lohr, J.B., Underhill, S., Moir, S., Jeste, D.V. (1990) Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia. Biol. Psychiatry 28, 535-539.
101. MacGee, J. (1959) Enzymatic determination of polyunsaturated fatty acids. Analyt. Chem. 31, 298-302.
102. McCord, J.M. and Fridovich, I. (1969) Superoxide dismutase - an enzymic function for erythrocuprein (hemocuprein). J. Biol. Chem. 244, 6049-6055.
103. Mahadik, S.P., Mukherjee, S., Laev, H., Reddy, R. and Schnur, D. (1991) Abnormal growth and morphology of fibroblasts from schizophrenic patients. Psychiatry Res. 37, 309-320.
104. Mahadik, S.P., Mukherjee, S., Correnti, E., Kelkar, H.S., Wakade, C.G., Costa, R.M. and Scheffer, R. (1994a) Distribution of plasma membrane phospholipids and cholesterol in skin fibroblasts from drug-naive patients at the onset of psychosis. Schizophr. Res. 13, 239-247.
105. Mahadik, S.P., Mukherjee, S., Correnti, E.E., Mahadik, J.S. and Scheffer, R. (1995b) Mitogenic response to basic fibroblast growth factor (bFGF) of skin fibroblasts from first-episode psychotic, chronic schizophrenic and bipolar patients. Schizophr. Res. 15, 66.
106. Mahadik, S.P., Mukherjee, S., Correnti, E.E., and Scheffer, R. (1995a) Elevated levels of lipid peroxidation products in plasma from drug-naive patient at the onset of psychosis. Schizophr. Res. 15, 66.
107. Mahadik, S.P., Mukherjee, S., Wakade, C.G., Laev, H. and Reddy, R. (1994b) Decreased adhesiveness and altered cellular distribution of fibronectin in fibroblasts from schizophrenic patients. Psych. Res. 53, 87-97.
108. Mahadik, S.P., Wakade, C.G., Scheffer, R., Correnti, E., Borison, R.L. and Mukherjee, S. (1993) Abnormal growth of skin fibroblasts from drug-naive psychotic patients. Biol. Psychiatry 33, 69A.
109. ++ mobilization in Xenopus oocytes. Proc. Natl. Acad. Sci. USA 87, 2196-2200.
110. Masoro, E.J. (1984) A critical review: Nutrition and aging - a current assessment. J. Nutr. 115, 842-848.
111. Mattson, M.P. and Rychlik, B. (1990) Cell culture of cryopreserved human fetal cerebral cortical and hippocampal neurons: neuronal development and responses to trophic factors. Brain Res. 522, 204-214.
112. Mattson, M.P., Murrain, M., Guthrie, P.B. and Kater, S.B. (1993) Fibroblast growth factor and glutamate: opposing roles in the generation and degeneration of hippocampal neuroarchitecture. J. Neurosci. 9, 3728-3740.
113. Mavelli, I., Rigo, A., Federico, R., Ciriolo, M.R. and Rotilio, G. (1982) Superoxide dismutase, glutathione peroxidase and catalase in developing rat brain. Biochem. J. 204, 535-540.
114. Mellow-Filho, A.C. and Meneghini, R. (1984) In vivo formation of single strand breaks in DNA by hydrogen peroxide is mediated by the Haber-Weiss reaction. Biochim. Biophys. Acta. 781, 56-63.
115. Michelson, A.M. (1982) Clinical use of superoxide dismutase and possible pharmacological approaches. In Autor, A.P. (ed), Pathology of oxygen. Academic Press, Orlando, FL pp. 277-302.
116. Michelson, A.M., Puget, K., Durosay, P. and Bouneau, J.C. (1977) Clinical aspects of the dosage of erythrocuprein. In Michelson, A.M., McCord, J.M. and Fridovich, I. (eds), Superoxide and Superoxide Dismutase. Academic Press, London, pp. 467-499.
117. Miguel, A., Quintanilha, A.T. and Weber, H. (Eds.) (1989). CRC Handbook of Free Radicals and Antioxidants in Biomedicine. Vois. I-III. CRC Press Inc. Boca Raton, FL.
118. Moncada, S., Palmer, R.M.J. and Higgs, E.A. (1991) Nitric oxide physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43, 109-142.
119. Montague, P.R., Gancayo, C.D., Winn, M.J., Marchase, R.B. and Friedlander, M.J. (1994) Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex. Science 263, 973-977.
120. Mukherjee, S., Reddy, R. and Schnur, D. (1991) Developmental model of negative syndromes in schizophrenia. In Greden, J. and Tandon, R. (Eds), Negative Schizophrenic Syndromes. Am. Psych. Press, Washington. DC. pp. 175-185.
121. Mukherjee, S., Mahadik, S.P., Horrobin, D.F., Jenkins, K., Correnti, E. and Scheffer, R. (1994a) Membrane fatty acid composition of fibroblasts from schizophrenic patients. Biol. Psychiatry 35, 700.
122. Mukherjee, S., Mahadik, S.P., Schnur, D., Heljo, L. and Reddy, R. (1994b) Abnormal growth of cultured skin fibroblasts associated with poor premorbid history in schizophrenic patients. Schizophr. Res. 13, 233-237.
123. Mukherjee, S., Mahadik, S.P., Scheffer, R., Correnti, E., and Kelkar, H. (1996a) impaired antioxidant defense at the onset of psychosis. Schizophr. Res. in press.
124. Mukherjee, S., Mahadik, S.P., Correnti, E.E. and Scheffer, R. (1996b) Early recurrence of psychosis after recovery from a first episode: Possible role of oxidative stress. Biol. Psychiatry, in press.
125. Nathan, C.F., Brukner, L.H., Silverstein, S.C. and Cohen, Z. (1979) Extracellular cytolysis by activated macrophases and granulocytes. I. Pharmacological trigger of effector cells and the release of hydrogen peroxide. J. Exp. Med. 149, 84-99.
126. Nistico, G., Ciriolo, M.R., Fiskin, K., Iannone, M., Martino, A and Rotillo, G. (1992) NGF restoeres decreases in catalase activity and increases superoxide dismutase and glutathione peroxidase activity in the brain of aged rats. Free Radical Biol. & Med. 12, 177-181.
127. Nohl, H., Breuninger, V. and Hegner, D. (1978) Influence of mitochondrial radical formation of energy-linked respiration. Eur. J. Biochem. 90, 385-390.
128. Nyberg, P., Carlson, A. and Winblad, B. (1982) Brain monoamines in cases with Downis syndrome with and without dementia. J. Neural Transmission. 55, 289.
129. Ohkawa, H., Ohishi, N. and Yagi, K. (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95, 351-358.
130. Packer, L. (Ed.) (1984) Oxygen Radicals in Biological Systems. Methods in Enzymology Vol. 105. Academic Press, New York.
131. Pan, Z. and Perez-Polo, R. (1993) Role of nerve growth factor in oxidant homeostasis: glutathione metabolism. J. Neurochem. 61, 1713-1721.
132. Peet, M., Laugharne, J., Rangarajan, N. and Renolds G.P. (1993) Tardive dyskinesia, lipid peroxidation, and sustained amelioration with vitamin E treatment. Intl. Clin. Psychopharmacology 8, 151-153.
133. Piomelli, D., Pilon, C., Giros, B., Sokoloff, P., Martres, M.-P. and Schwartz, J.-C. (1991) Dopamine activation of the arachidonic acid cascade as a basis for D1/D2 receptor synergism. Nature 353, 164-167.
134. Prohaska, J.R. and Ganther, H.E. (1976) Selenium and glutathione peroxidase in developing rat brain. J. Neurochem. 27, 1379-1387.
135. Radi, R., Beckman, J.S., Bush, K.M., and Freeman, B.A. (1991) Peroxinitrite oxidation of sufhydryls. The cytotoxic potential of superoxide and nitric oxide. J. Biol. Chem. 266, 4244-4250.
136. Rafalowska, U., Liu G.-J. and Floyd, R.A. (1989) Peroxidation induced changes in synaptosomal transport of dopamine and γ-aminobutyric acid. Free Radical Biol. Med. 6, 485-492.
137. Ramasarma, T. (1986) An iron-messenger system - a hypothesis. Free Radical Res. Comm. 2, 153-162.
138. Reddy, R., Mahadik, S.P., Mukherjee, S. and Murthy, J.N. (1991) Enzymes of the antioxidant defense system in chronic schizophrenic patients. Biol. Psychiatry 30: 409-412.
139. Reddy, R., Mahadik, S.P., Mukherjee, S. and Makar, T. (1992) Neuroleptic effects on the enzymes of the anti-oxidant defense system in manic and schizophrenic patients. Biol. Psychiatry 31, 248A.
140. Reddy, R., Kelkar, H., Mahadik, S.P. and Mukherjee, S. (1993) Abnormal erythrocyte catalase activity in schizophrenic patients. Schizophr. Res. 9, 227.
141. Rotilo, G. (Ed.) (1986) Superoxide and Superoxide Dismutase in Chemistry, Biology and Medicine. Elsevier Press, Amsterdam.
142. Rotrosen, J. and Wolkin, A. (1987) Phospholipid and prostaglandin hypotheses of schizophrenia. In Meltzer H.Y. (ed), Psychopharmacology: The Third Generation of Progress. New York: Raven Press, pp. 759-764
143. Samullsson, B., Goldyne, M., Granstoom, E., Hamburg, M., Hammerstrom, S. and Malmsten, C. (1978) Prostaglandinsand thromboxanes, Ann. Rev. Biochem. 42, 997-1029.
144. Savolainen, H. (1978) Superoxide dismutase and glutathione peroxidase activities in rat brain. Res. Commun. Chem. Pathol. Pharm. 21, 173-176.
145. Scapicchio, P., Decina, P., Mukherjee, S. and Caracci, G. (1991) Effects of (-tocopherol on persistent tardive dyskinesia in elderly schizophrenic patients. Italian J. Psych. Behav. Sci. 1, 111-114.
146. Scarpa, M., Rigo, A., Viglino, P., Stevanato, R., Bracco, F. and Battistin, L. (1987) Age dependence of the levels of the enzymes involved in the protection against active oxygen species in the rat brain. Proc. Soc. Exptl. Biol. Med. 185, 129-135.
147. Scheibel, A.B. and Kovelman, J.A. (1981) Disorientation of the hippocampal pyramidial cell and its processes in the schizophrenic patient. Biol. Psychiatry 16, 101-2.
148. Schwartz, R.D., Skolnick, P. and Paul, S.M. (1988) Regulation of γ-aminobutyric acid/barbiturate receptor gated chloride ion flux in brain vesicles by phospholipase A2: Possible role of oxygen radicals. J. Neurochem. 50, 565-571.
149. Seeman, P., Niznik, H.B., Guan, H.-C., Booth, G. and Ulpian, C. (1989) Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain. Proc. Natl. Acad. Sci. USA. 86, 10156-10160.
150. Segal, D.J. and McCoy, E.E. (1974) Studies on Down's syndrome in tissue culture: growth rates and protein rates of fibroblast cultures. J. Cell Physiol. 83, 85.
151. Shepherd, R.A., Bates, P.R., & McGrath, J.J. (1993). Cell cycle characteristics after ionising radiation induced DNA damage in schizophrenia. Biol. Psychiatry, 33, 60-61.
152. Simon, R.H., Scoggin, C.H. and Patterson, D. (1981) Hydrogen peroxide causes the fatal injury to human fibroblasts exposed to oxygen radicals. J. Biol. Chem. 256, 7181.
153. Sinet, P.M., Debray, Q., Carmagnol, F., Pelicier, Y., Nicole, A. and Jerome, H. (1983) Normal erytrocyte SOD values in two human diseases: Schizophrenia and cystic fibrosis. In Greenwald, R.A. and Cohen, G. (Eds), Oxy Radicals and their Scavenger Systems. Vol. II: Cellular and Medical Aspects. Elsevier Press, New York. pp. 302-304.
154. Sohal, R.S., Sohal, B.H. and Brunk, U.F. (1990) relationship between antioxidant defenses and longevity in different mammalian species. Mech. Aging Dev. 53, 217-227.
155. Sohal, R.S., Ku, H.-H., Agarwal, S., Forster, M.J. and Lal, H. (1994) Oxidative damage, mitochondrial oxidant generation and antioxidant defenses during aging and in response to food restriction in the mouse. Mech. Aging Dev. 74, 121-133.
156. Somville, M. and Remade, J. (1980) Comparative study of mitochondrial and cytoplasmic dismutase during aging of human fibroblasts in culture. In: Bannister, W.H. and Bannister, J.V. (Eds), Bioloigical and Clinical Aspects of Superoxide and Superoxide Dismutase. Elsevier North Holland, New York. pp. 292-293.
157. Spina, M.B., Squinto, S.P., Miller, J., Lindsay, R.M. and Hyman, C. (1992) Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenyl-pyridirium ion toxicity: involvement of the glutathione system. J. Neurochem. 59, 99-106.
158. Stadtman, E.R. (1992) Protein oxidation and aging. Science 257, 1220-1224.
159. Straw, G.M., Bigelo, L.B. and Kirch, D.G. (1989) Haloperidol and reduced haloperidol concentrations and psychiatric rating in schizophrenic patients treated with ascorbic acid. J. Clin. Psychopharrn. 9, 130-132.
160. Stokiasova, A., Zapletalek, M., Kudrnova, K. and Randova, Z. (1986) Glutathione peroxidase activity of blood in chronic schizophrenics. Sborniku Vedeckych Praci Lekarske Fakulty UK v Hradci Kralove 29 (1-2): 103-108.
161. Suboticanec, K., Folnegovic, V., Korbar, M., Mestrovic, B. and Buzina, R. (1990) Vitamin C status in chronic schizophrenia. Biol. Psychiatry 28, 959-966.
162. Subramaniam, B., Rollema, H., Woolf. T. and Castagnoli, N.G. (1990) Identification of a potentially neurotoxic pyrindinium metabolite of Lalopeindol in rats. Biochem. Bio phys. Res. Commun. 166, 238-244.
163. Suddath, R.L., Christison, G.W., Torrey, E.F., Casanova, M.F. and Weinberger, D.R. (1990) Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia. N. Engl. J. Med. 322, 789-794.
164. Suzuki, K. (1981) Chemistry and metabolism of brain lipids. In, Siegel, G.J., Albers, R.W., Agranoff B.W. and Katzman, R. (eds), Basic Neurochemistry, 3rd ed. Little, Brown and Company, Boston, MS. pp. 355-370.
165. Szabo, L., Lajko, K., Barabas, K. and Matkovics, B. (1983) Effects of neuroleptics on lipid peroxidation and peroxide metabolism enzyme activities in various discrete areas of the brain. Chem. Pharmacol. 14, 537-539.
166. Taylor, W.J., Camalier, R.F. and Sanford, K.K. (1978) Density-dependent effects of oxygen on the growth of mammalian fibroblasts in culture. J. Cell. Physiol. 95, 33-40.
167. Vaddadi, K.S., Courtney, P., Gilleard, C.S., Manku, M.S. and Horrobin, D.F. (1989) A double-blind trial of essential fatty acid supplementation in patients with tardive dyskinesia. Psych. Res. 27, 313-323.
168. Vallar, L. and Meldolesi, J. (1987) Mechanisms of signal transduction at the dopamine D2 receptor. Trends Pharmacol. Sci. 10, 74-77.
169. Virdee, K., Brown, B.L., and Dobson, P.R.M. (1994) Stimulation of arachidonic acid release from swiss 3T3 cells by recombinant basic fibroblast growth factor: independence from phosphoinositide turnover. Biochim. Biophys. Acta 1220, 171-180.
170. Vitorica, J., Machado, A. and Satrustegui, J. (1984) Age-dependent variations in peroxide-utilizing enzymes from rat brain mitochondria and cytoplasm. J. Neurochem. 42, 351-356.
171. Wolff, S.P. and Dean, R.T. (1986) Fragmentation of proteins by free radicals and its effect on their susceptibility to enzymic hydrolysis. Biochem. J. 234, 399-403.
172. Weinberger, D.R. (1987) Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry 44, 660-9.
173. Wise, C.D., Baden, M.M., Stein, L. (1974) Post-mortem measurement of enzymes of human brain: evidence of a central non-adrenergic deficit in schizophrenia. J. Psychiatric Res. 11, 185-198.
174. Yamamoto, I., Adachi, N., Kurogochi, Y. and Tsyjimoto, A. (1960) Effects of chlorpromazine on enzymic reaction involving metal ions. Jpn. J. Pharmacol. 10, 38-46.
175. Yao, J.K., van Kammen, D.P., Gurkis, W.J. (1994) Correlation of fatty acid abnormalities with clinical measures in schizophrenia. Schizophr. Res. 11, 124.
176. Yusa, T., Crapo, J.D. and Freeman, B.A. (1984) Liposome-mediated augmentation of brain SOD and catalase inhibits CNS O2 toxicity. J. Applied Physiol. 57, 1674.